The pharmaceutical world is seeing a significant shift in diabetes management with the arrival of GLP-1 transdermal devices. These systems offer a possibly more convenient alternative to injections of GLP-1 medications, lessening the need for daily needle sticks. The innovation releases the drug directly through the epidermis, potentially enhancing